CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026

Crystallisation Development – A Quality by Design Approach using Modelling

Nearly all synthetic steps in industrial chemical manufacturing end with crystallisation. This is because it is almost always the most efficient method to purify and isolate the material. While most chemists are proficient at coming up with a basic procedure, when it comes down to the fine details, often crystallisation is seen as a mysterious process and subject to factors beyond our control. Various quality issues may be important for the product: purity, residual solvents, filtration speed, polymorph, crystal habit, and particle size distribution. Steve Winter at Solitek explains how an in-depth understanding of the crystallisation process will help keep these issues under control.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026